The appropriate vascular access for hemodialysis in patients with cardiac implantable electronic devices (CIED) is undefined. We describe two cases of end-stage renal disease patients with CIED and tunneled central venous catheter (CVC) who developed venous cava stenosis: (1) a 70-year-old man with sinus node disease and pacemaker in 2013, CVC, and a Brescia-Cimino forearm fistula in 2015; (2) a 75-year-old woman with previous ventricular arrhythmia with implanted defibrillator in 2014 and CVC in 2016. In either case, after about 1 year from CVC insertion, patients developed superior vena cava (SVC) syndrome due to stenosis diagnosed by axial computerized tomography. In case 1, the patient was not treated by angioplasty of SVC and removed CVC with partial resolving of symptoms. In case 2, a percutaneous transluminal angioplasty with placement of a new CVC was required. To analyze these reports in the context of available literature, we systematically reviewed studies that have analyzed the presence of central venous stenosis associated with the simultaneous presence of CIED and CVC. Five studies were found; two indicated an increased incidence of central venous stenosis, while three did not find any association. While more studies are definitely needed, we suggest that these patients may benefit from epicardial cardiac devices and the insertion of devices directly into the ventriculus. If the new devices are unavailable or contraindicated, peritoneal dialysis or intensive conservative treatment in older patients may be proposed as alternative options.

1.
United States Renal Data System
.
2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States
.
Bethesda (MD)
:
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
;
2016
.
2.
Asif
A
,
Salman
L
,
Lopera
G
,
Haqqie
SS
,
Carrillo
R
.
Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination
.
Semin Dial
.
2012
Sep-Oct
;
25
(
5
):
582
6
.
[PubMed]
0894-0959
3.
Bhadauria
D
,
Chellappan
A
,
Gurjar
M
,
Kaul
A
,
Sharma
RK
,
Prasad
N
.
The “dilemma of double lifelines”: central venous catheter co-existence with transvenous cardiac pacemaker
.
J Vasc Access
.
2017
Jan
;
18
(
1
):
e3
5
.
[PubMed]
1129-7298
4.
Rice
TW
,
Rodriguez
RM
,
Light
RW
.
The superior vena cava syndrome: clinical characteristics and evolving etiology
.
Medicine (Baltimore)
.
2006
Jan
;
85
(
1
):
37
42
.
[PubMed]
0025-7974
5.
Saad
TF
,
Ahmed
W
,
Davis
K
,
Jurkovitz
C
.
Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions
.
Semin Dial
.
2015
Jan-Feb
;
28
(
1
):
94
100
.
[PubMed]
0894-0959
6.
Pipili
C
,
Cholongitas
E
,
Tzanatos
H
.
Two cases of silent superior vena cava syndrome associated with vascular access and end-stage renal disease
.
Int J Artif Organs
.
2009
Dec
;
32
(
12
):
883
8
.
[PubMed]
0391-3988
7.
Santoro
D
,
Postorino
A
,
Condemi
CG
,
Lamberto
S
,
Savica
V
,
Benedetto
F
, et al.
Tunneled dialysis catheter and pacemaker leads determining superior vena cava syndrome
.
J Vasc Access
.
2011
Jul-Sep
;
12
(
3
):
271
2
.
[PubMed]
1129-7298
8.
Aurshina
A
,
Hingorani
A
,
Alsheekh
A
,
Kibrik
P
,
Marks
N
,
Ascher
E
.
Placement issues of hemodialysis catheters with pre-existing central lines and catheters
.
J Vasc Access
.
2018
Jul
;
19
(
4
):
366
9
.
[PubMed]
1129-7298
9.
US Renal Data System. Excerpts from the United States Renal Data System 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States
.
Am J Kidney Dis
.
2009
;
53
(
1
suppl 1
):
S257
70
.0272-6386
10.
Kusztal
M
,
Nowak
K
.
Cardiac implantable electronic device and vascular access: strategies to overcome problems
.
J Vasc Access
.
2018
Nov
;
19
(
6
):
521
7
.
[PubMed]
1129-7298
11.
Teruya
TH
,
Abou-Zamzam
AM
 Jr
,
Limm
W
,
Wong
L
,
Wong
L
.
Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers
.
Ann Vasc Surg
.
2003
Sep
;
17
(
5
):
526
9
.
[PubMed]
0890-5096
12.
Haghjoo
M
,
Nikoo
MH
,
Fazelifar
AF
,
Alizadeh
A
,
Emkanjoo
Z
,
Sadr-Ameli
MA
.
Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade
.
Europace
.
2007
May
;
9
(
5
):
328
32
.
[PubMed]
1099-5129
13.
Da Costa
SS
,
Scalabrini Neto
A
,
Costa
R
,
Caldas
JG
,
Martinelli Filho
M
.
Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study
.
Pacing Clin Electrophysiol
.
2002
Sep
;
25
(
9
):
1301
6
.
[PubMed]
0147-8389
14.
Deighan
CJ
,
McLaughlin
KJ
,
Simpson
K
,
Jones
JM
.
Unsuspected subclavian vein stenosis resulting from a permanent pacing wire
.
Nephrol Dial Transplant
.
1996
Nov
;
11
(
11
):
2333
4
.
[PubMed]
0931-0509
15.
Korzets
A
,
Chagnac
A
,
Ori
Y
,
Katz
M
,
Zevin
D
.
Subclavian vein stenosis, permanent cardiac pacemakers and the haemodialysed patient
.
Nephron
.
1991
;
58
(
1
):
103
5
.
[PubMed]
0028-2766
16.
Tourret
J
,
Cluzel
P
,
Tostivint
I
,
Barrou
B
,
Deray
G
,
Bagnis
CI
.
Central venous stenosis as a complication of ipsilateral haemodialysis fistula and pacemaker
.
Nephrol Dial Transplant
.
2005
May
;
20
(
5
):
997
1001
.
[PubMed]
0931-0509
17.
Chuang
CL
,
Tarng
DC
,
Yang
WC
,
Huang
TP
.
An occult cause of arteriovenous access failure: central vein stenosis from permanent pacemaker wire. Report of three cases and review of the literature
.
Am J Nephrol
.
2001
Sep-Oct
;
21
(
5
):
406
9
.
[PubMed]
0250-8095
18.
Asif
A
,
Salman
L
,
Carrillo
RG
,
Garisto
JD
,
Lopera
G
,
Barakat
U
, et al.
Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study
.
Semin Dial
.
2009
Nov-Dec
;
22
(
6
):
671
6
.
[PubMed]
0894-0959
19.
Ailawadi
G
,
Lapar
DJ
,
Swenson
BR
,
Maxwell
CD
,
Girotti
ME
,
Bergin
JD
, et al.
Surgically placed left ventricular leads provide similar outcomes to percutaneous leads in patients with failed coronary sinus lead placement
.
Heart Rhythm
.
2010
May
;
7
(
5
):
619
25
.
[PubMed]
1547-5271
20.
Asif
A
,
Carrillo
R
,
Garisto
JD
,
Lopera
G
,
Ladino
M
,
Barakat
U
, et al.
Epicardial cardiac rhythm devices for dialysis patients: minimizing the risk of infection and preserving central veins
.
Semin Dial
.
2012
Jan-Feb
;
25
(
1
):
88
94
.
[PubMed]
0894-0959
21.
Reynolds
D
,
Duray
GZ
,
Omar
R
,
Soejima
K
,
Neuzil
P
,
Zhang
S
, et al.;
Micra Transcatheter Pacing Study Group
.
A Leadless Intracardiac Transcatheter Pacing System
.
N Engl J Med
.
2016
Feb
;
374
(
6
):
533
41
.
[PubMed]
0028-4793
22.
Yeates
K
,
Zhu
N
,
Vonesh
E
,
Trpeski
L
,
Blake
P
,
Fenton
S
.
Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada
.
Nephrol Dial Transplant
.
2012
Sep
;
27
(
9
):
3568
75
.
[PubMed]
0931-0509
23.
Pacilio
M
,
Minutolo
R
,
Garofalo
C
,
Liberti
ME
,
Conte
G
,
De Nicola
L
.
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question
.
J Nephrol
.
2016
Apr
;
29
(
2
):
153
61
.
[PubMed]
1121-8428
24.
Brunori
G
,
Viola
BF
,
Parrinello
G
,
De Biase
V
,
Como
G
,
Franco
V
, et al.
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study
.
Am J Kidney Dis
.
2007
May
;
49
(
5
):
569
80
.
[PubMed]
0272-6386
25.
Di Lullo
L
,
Floccari
F
,
Polito
P
.
Right ventricular diastolic function in dialysis patients could be affected by vascular access
.
Nephron Clin Pract
.
2011
;
118
(
3
):
c257
61
.
[PubMed]
1660-2110
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.